The journey of a disease-modifying osteoarthritis drug: From research to reality
This episode of Joint Action discusses the development of disease-modifying osteoarthritis drugs (DMOADs) with Professor David Hunter, Chris Knight, and Dr. Sandeep Basnet. They cover challenges in clinical trials, drug development, and the potential impact of AI on future…